|
Market Closed -
Australian S.E.
01:54:51 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.3675 AUD | -2.00% |
|
+0.68% | -43.46% |
| Market Cap | 110M 78.96M 68.04M 63.79M 58.23M 110M 7.55B 757M 295M 3.81B 296M 290M 12.63B | P/E 2026 * |
-6.02x | P/E 2027 * | -4.32x |
|---|---|---|---|---|---|
| Enterprise Value | 115M 82.72M 71.28M 66.83M 61M 115M 7.91B 793M 309M 3.99B 311M 304M 13.23B | EV / Sales 2026 * |
14.8x | EV / Sales 2027 * | 10.8x |
| Free-Float |
62.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.00% | ||
| 1 week | +0.68% | ||
| Current month | -0.68% | ||
| 1 month | +0.68% | ||
| 3 months | -34.38% | ||
| 6 months | -31.94% | ||
| Current year | -43.46% |
| 1 week | 0.36 |  | 0.38 |
| 1 month | 0.36 | | 0.38 |
| Current year | 0.35 | | 0.73 |
| 1 year | 0.35 | | 0.73 |
| 3 years | 0.28 | | 0.73 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 2020-08-27 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 2012-09-30 |
James Graham
BRD | Director/Board Member | - | 2012-04-30 |
| Director/Board Member | - | 2022-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 7/31/26 | Buy | Director | 75,000 | 0.0250% | ||
| 7/31/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.00% | +0.68% | -12.50% | -48.24% | 78.96M | |
| -0.13% | -6.44% | +60.47% | +112.05% | 1,047B | |
| +0.85% | -0.81% | +52.77% | +63.15% | 646B | |
| -1.03% | -3.58% | +22.87% | +73.29% | 451B | |
| -1.46% | -4.50% | +37.43% | +38.41% | 355B | |
| -0.72% | -2.89% | +21.86% | +36.79% | 291B | |
| -1.19% | -2.21% | +1.35% | +12.29% | 252B | |
| -1.05% | -1.57% | +51.40% | +68.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.29% | 203B | |
| -2.14% | -0.30% | +29.42% | +89.10% | 181B | |
| Average | -0.89% | -2.34% | +24.75% | +39.11% | 365.94B | |
| Weighted average by Cap. | -0.48% | -3.46% | +38.66% | +65.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.78M 5.58M 4.81M 4.51M 4.12M 7.75M 533M 53.5M 20.87M 269M 20.95M 20.5M 893M | 12.5M 8.97M 7.73M 7.24M 6.61M 12.46M 857M 85.93M 33.53M 433M 33.66M 32.93M 1.43B |
| Net income | -18.29M -13.12M -11.31M -10.6M -9.68M -18.23M -1.25B -126M -49.08M -633M -49.27M -48.2M -2.1B | -25.1M -18.01M -15.52M -14.55M -13.28M -25.02M -1.72B -173M -67.35M -869M -67.61M -66.14M -2.88B |
| Net Debt | 5.24M 3.76M 3.24M 3.03M 2.77M 5.22M 359M 36M 14.05M 181M 14.1M 13.79M 601M | 24.96M 17.91M 15.43M 14.47M 13.21M 24.88M 1.71B 172M 66.98M 864M 67.24M 65.78M 2.87B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | A$0.3675 | -2.00% | 116,709 |
| 26-08-27 | A$0.3750 | -1.32% | 189,511 |
| 26-08-26 | A$0.3800 | +1.33% | 100,215 |
| 26-08-25 | A$0.3750 | +1.35% | 38,796 |
| 26-08-24 | A$0.3700 | +1.37% | 21,429 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
